598 results on '"Kamakura, Tsukasa"'
Search Results
2. Usefulness of preprocedural identification of surgical incision sites and patches by computed tomography for ventricular tachycardia ablation in a patient with tetralogy of Fallot
3. Evaluation of synchronized left ventricular pacing rate over biventricular pacing in cardiac resynchronization therapy
4. Demonstration of Arrhythmia Substrate-Associated Dispersion of Repolarization by Epicardial Unipolar Mapping in Brugada Syndrome
5. Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with “mid-range” QRS duration
6. Implications of ventricular arrhythmia after cardiac resynchronization therapy
7. N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
8. Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac Function
9. Left Ventricular Abnormal Substrate in Brugada Syndrome
10. Electrophysiologic Determinants of Isoelectric Intervals on Surface Electrocardiograms During Atrial Tachycardia: Insights From High-Density Mapping
11. Omnipolar versus bipolar mapping to guide ventricular tachycardia ablation
12. Significance of effective cardiac resynchronization therapy pacing for clinical responses: An analysis based on the effective cardiac resynchronization therapy algorithm
13. Abstract 13558: Age-Dependent Change of Electrocardiographic Characteristics and Cardiac Events in the Long QT Syndrome Type-3 With E1784K Mutation of SCN5A
14. Abstract 13515: Continuous Optimization of Atrioventricular Pacing Timing of Cardiac Resynchronization Therapy in Heart Failure Patients With Pacemaker Dependency
15. Abnormal Atrial Potentials Recorded During Sinus Rhythm or Pacing Represent Substrates for Reentrant Atrial Tachycardia
16. High-resolution mapping of reentrant atrial tachycardias: Relevance of low bipolar voltage
17. Gaps after linear ablation of persistent atrial fibrillation (Marshall-PLAN): Clinical implication
18. Impact of nocturnal hypoxemia on the recurrence of atrial tachyarrhythmia after catheter ablation of atrial fibrillation
19. Outcome of patients with early repolarization pattern and syncope
20. Sex-related differences in the prognosis of patients with cardiac sarcoidosis treated with cardiac resynchronization therapy
21. Sinus node exit, crista terminalis conduction, interatrial connection, and wavefront collision: Key features of human atrial activation in sinus rhythm
22. Optimized Computed Tomography Acquisition Protocol for Ethanol Infusion Into the Vein of Marshall
23. Local dispersion of repolarization in the occurrence of ventricular fibrillation in Brugada syndrome: Possibility of phase 2 reentry?
24. Epicardial course of the musculature related to the great cardiac vein: Anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion
25. Sex differences in the origin of Purkinje ectopy-initiated idiopathic ventricular fibrillation
26. Role of endocardial ablation in eliminating an epicardial arrhythmogenic substrate in patients with Brugada syndrome
27. Persistent atrial fibrillation ablation in cardiac laminopathy: Electrophysiological findings and clinical outcomes
28. Significance of manifest localized staining during ethanol infusion into the vein of Marshall
29. Abstract 11446: Impact of Higher Synchronized Left Ventricular Pacing Rate for Prognosis on Cardiac Resynchronization Therapy
30. Abstract 11307: Longer Outflow Tract Conduction Time by Magnetocardiography as a Novel Non-Invasive Maker for Predicting Lethal Events in Patients With Brugada Syndrome Without Ventricular Fibrillation
31. Abstract 10183: Structural Characteristics of Patients With Superior Vena Cava Foci Initiating Atrial Fibrillation: Analysis With Electrocardiogram-Triggered Computed Tomography
32. Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion
33. Relationship between electrical gaps after Maze procedure and atrial tachyarrhythmias and ablation outcomes after cardiac surgery and concomitant Maze procedure
34. Clinical impact of left ventricular paced conduction disturbance in cardiac resynchronization therapy
35. Implantable loop recorder uncovered torsades de pointes in long-QT syndrome type 1 with multi cause of syncope.
36. Late life‐threatening arrhythmia in patients with Brugada syndrome: Results from long‐term follow‐up in a large Japanese cohort.
37. Usefulness of preprocedural identification of surgical incision sites and patches by computed tomography for ventricular tachycardia ablation in a patient with tetralogy of Fallot
38. Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia
39. Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome
40. ERS in Relation to Brugada Syndrome
41. Clinical Differences in Japanese Patients Between Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy With Long-Term Follow-Up
42. Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome
43. Catheter Ablation for Atrial Fibrillation in Hyperthyroid Patients
44. Comparison Between Septal Pacing With the Catheter Delivery System and Apical Pacing With the Stylet Delivery System for Ventricular Lead Placement: A Randomized Controlled Trial
45. Vein of Marshall Ethanol Infusion: Feasibility, Pitfalls, and Complications in Over 700 Patients
46. Implications of Ventricular Arrhythmia After Cardiac Resynchronization Therapy
47. Abnormal Arrhythmogenic Substrate Outside the Right Ventricular Outflow Tract Detected by a Drug Challenge Test in a Patient With Brugada Syndrome
48. Ventricular fibrillation initiated by reentry involving the Purkinje network in a patient with after myocardial infarction
49. Feasibility of Catheter Ablation for Biatrial Tachycardia Using Multiple Catheters via an Atrial Shunt Device
50. Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.